FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controls

International Journal of Neuropsychopharmacology

Volumn 18, Issue 4, 2014, Pages 1-9

  Höhne, Nina ^a   Poidinger, Maximilian ^a   Merz, Franziska ^a   Pfister, Hildegard ^a   Brückl, Tanja ^a   Zimmermann, Petra ^a   Uhr, Manfred ^a   Holsboer, Florian ^a,b   Ising, Marcus ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b HMNC GmbH   (Germany)

Author keywords

DNA methylation; FKBP5; Gene expression; HPA axis; Major Depression

Indexed keywords

BETA GLUCURONIDASE; CORTICOTROPIN; FK 506 BINDING PROTEIN; FK506 BINDING PROTEIN 5; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HYDROCORTISONE; MESSENGER RNA; PHOSPHOLIPASE A; TATA BINDING PROTEIN; UNCLASSIFIED DRUG; TACROLIMUS BINDING PROTEIN 5;

ADULT; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CPG ISLAND; DNA METHYLATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; INTRON; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL HISTORY; MENTAL STRESS; NEGATIVE FEEDBACK; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; BLOOD; GENETICS; PERCEPTION;

ADRENOCORTICOTROPIC HORMONE; ADULT; DEPRESSIVE DISORDER, MAJOR; DNA METHYLATION; FEMALE; GENOTYPE; HUMANS; HYDROCORTISONE; INTRONS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; SOCIAL PERCEPTION; STRESS, PSYCHOLOGICAL; TACROLIMUS BINDING PROTEINS;

EID: 84926637212     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyu087     Document Type: Article

References (40)

1. Appel K, Schwahn C, Mahler J, Schulz A, Spitzer C, Fenske K, Stender J, Barnow S, John U, Teumer A, Biffar R, Nauck M, Volzke H, Freyberger HJ, Grabe HJ (2011) Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology 36:1982-1991.
2. Binder EB (2009) The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrino 34 Suppl 1:S186-195.
3. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, Tang Y, Gillespie CF, Heim CM, Nemeroff CB, Schwartz AC, Cubells JF, Ressler KJ (2008) Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299:1291-1305.
4. Binder EB et al. (2004) Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36:1319-1325.
5. Buchmann AF, Holz N, Boecker R, Blomeyer D, Rietschel M, Witt SH, Schmidt MH, Esser G, Banaschewski T, Brandeis D, Zimmermann US, Laucht M (2014) Moderating role of FKBP5 genotype in the impact of childhood adversity on cortisol stress response during adulthood. Eur Neuropsychopharm 24:837-845.
6. Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, Craig IW, Anacker C, Zunsztain PA, McGuffin P, Pariante CM (2013) Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacology 38:377-385.
7. Cohen J (1988) Statistical Power analysis for the behavioral sciences. Hillsdale: Erlbaum.
8. Denny WB, Valentine DL, Reynolds PD, Smith DF, Scammell JG (2000) Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology 141:4107-4113.
9. Hautzinger M, Keller F, Kühner C (2009) BDI-II. Beck-Depressions- Inventar. Frankfurt: Pearson Assessment.
10. Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477-501.
11. Ising M, Künzel HE, Binder EB, Nickel T, Modell S, Holsboer F (2005) The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuro-Psychoph 29:1085-1093.
12. Ising M, Depping AM, Siebertz A, Lucae S, Unschuld PG, Kloiber S, Horstmann S, Uhr M, Müller-Myhsok B, Holsboer F (2008) Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci 28:389-398.
13. Jääskeläinen T, Makkonen H, Palvimo JJ (2011) Steroid up-regulation of FKBP51 and its role in hormone signaling. Curr Opin Pharmacol 11:326-331.
14. Kirchheiner J, Lorch R, Lebedeva E, Seeringer A, Roots I, Sasse J, Brockmoller J (2008) Genetic variants in FKBP5 affecting response to antidepressant drug treatment. Pharmacogenomics 9:841-846.
15. Kirschbaum C, Pirke KM, Hellhammer DH (1993) The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28:76-81.
16. Klengel T, Binder EB (2013) Allele-specific epigenetic modification: a molecular mechanism for gene-environment interactions in stress-related psychiatric disorders? Epigenomics 5:109-112.
17. Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, Pace TW, Mercer KB, Mayberg HS, Bradley B, Nemeroff CB, Holsboer F, Heim CM, Ressler KJ, Rein T, Binder EB (2013) Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 16:33-41.
18. Lavebratt C, Aberg E, Sjoholm LK, Forsell Y (2010) Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. J Affect Disorders 125:249-255.
19. Lee RS, Tamashiro KL, Yang X, Purcell RH, Harvey A, Willour VL, Huo Y, Rongione M, Wand GS, Potash JB (2010) Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice. Endocrinology 151:4332-4343.
20. Lekman M, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ, Paddock S (2008) The FKBP5-gene in depression and treatment response-an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) Cohort. Biol Psychiat 63:1103-1110.
21. Lieb R, Isensee B, von Sydow K, Wittchen HU (2000) The Early Developmental Stages of Psychopathology Study (EDSP): a methodological update. Eur Addict Res 6:170-182.
22. Mehta D, Gonik M, Klengel T, Rex-Haffner M, Menke A, Rubel J, Mercer KB, Putz B, Bradley B, Holsboer F, Ressler KJ, Muller- Myhsok B, Binder EB (2011) Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch Gen Psychiat 68:901-910.
23. Meijer OC, de Lange EC, Breimer DD, de Boer AG, Workel JO, de Kloet ER (1998) Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 139:1789-1793.
24. Menke A, Klengel T, Binder EB (2012a) Epigenetics, depression and antidepressant treatment. Curr Pharm Design 18:5879-5889.
25. Menke A, Arloth J, Putz B, Weber P, Klengel T, Mehta D, Gonik M, Rex-Haffner M, Rubel J, Uhr M, Lucae S, Deussing JM, Muller- Myhsok B, Holsboer F, Binder EB (2012b) Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology 37:1455-1464.
26. Menke A, Klengel T, Rubel J, Bruckl T, Pfister H, Lucae S, Uhr M, Holsboer F, Binder EB (2013) Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression. Genes Brain Behav 12:289-296.
27. Paakinaho V, Makkonen H, Jääskeläinen T, Palvimo JJ (2010) Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions. Mol Endocrinol 24:511-525.
28. Pariante CM (2004) Glucocorticoid receptor function in vitro in patients with major depression. Stress 7:209-219.
29. Pariante CM (2009) Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids. Ann NY Acad Sci 1179:144-152.
30. Raison CL, Miller AH (2003) When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiat 160:1554-1565.
31. Touma C, Gassen NC, Herrmann L, Cheung-Flynn J, Bull DR, Ionescu IA, Heinzmann JM, Knapman A, Siebertz A, Depping AM, Hartmann J, Hausch F, Schmidt MV, Holsboer F, Ising M, Cox MB, Schmidt U, Rein T (2011) FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol Psychiat 70:928-936.
32. Vermeer H, Hendriks-Stegeman BI, van der Burg B, van Buul- Offers SC, Jansen M (2003) Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocr Metab 88:277-284.
33. Wagner KV, Marinescu D, Hartmann J, Wang XD, Labermaier C, Scharf SH, Liebl C, Uhr M, Holsboer F, Muller MB, Schmidt MV (2012) Differences in FKBP51 regulation following chronic social defeat stress correlate with individual stress sensitivity: influence of paroxetine treatment. Neuropsychopharmacology 37:2797-2808.
34. Wittchen HU, Perkonigg A, Lachner G, Nelson CB (1998) Early developmental stages of psychopathology study (EDSP): objectives and design. Eur Addict Res 4:18-27.
35. Wittchen HU, Pfister H (1997) DIA-X-Interviews: Manual für Screening-Verfahren und Interview; Interviewheft Längsschnittuntersuchung (DIA-X-Lifetime); Ergänzungsheft (DIA-X-Lifetime); Interviewheft Querschnittuntersuchung (DIA-X-12 Monate); Ergänzungsheft (DIA-X-12 Monate); PCProgramm zur Durchführung des Interviews (Längs- und Querschnittuntersuchung); Auswertungsprogramm. Frankfurt: Swets & Zeitlinger.
36. Wochnik GM, Ruegg J, Abel GA, Schmidt U, Holsboer F, Rein T (2005) FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 280:4609-4616.
37. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Farrer LA, Gelernter J (2010) Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 35:1684-1692.
38. Yehuda R, Daskalakis NP, Desarnaud F, Makotkine I, Lehrner AL, Koch E, Flory JD, Buxbaum JD, Meaney MJ, Bierer LM (2013) Epigenetic biomarkers as predictors and correlates of symptom improvement following psychotherapy in combat veterans with PTSD. Front Psychiatry 4:118.
39. Zimmermann P, Brückl T, Nocon A, Pfister H, Binder EB, Uhr M, Lieb R, Moffitt TE, Caspi A, Holsboer F, Ising M (2011) Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am J Psychiat 168:1107-1116.
40. Zobel A, Schuhmacher A, Jessen F, Hofels S, von Widdern O, Metten M, Pfeiffer U, Hanses C, Becker T, Rietschel M, Scheef L, Block W, Schild HH, Maier W, Schwab SG (2010) DNA sequence variants of the FKBP5 gene are associated with unipolar depression. Int J Neuropsychoph 13:649-660.